Literature DB >> 16143193

Growth and phenotype of low-density nasal septal chondrocyte monolayers.

David L Hicks1, August B Sage, Barbara L Schumacher, Robert L Sah, Deborah Watson.   

Abstract

OBJECTIVE: To analyze the growth patterns and differentiation of human septal chondrocyte monolayers of different seeding densities. STUDY
DESIGN: Chondrocytes from 8 donors were plated at densities ranging from 20,000 cells/cm(2) (high density) to 300 cells/cm(2) (very low density). Confluency, cellularity, and glycosaminoglycan content were determined from days 1 to 15.
RESULTS: Confluency was attained at 5.8, 8.3, 11.0, and 14.8 days for high-, intermediate-, low-, and very low-density monolayers, respectively (P < 0.001). Regression growth curves showed typical lag, logarithmic, and stationary phases. Confluent monolayers attained similar cellularity (power = 0.94) and differentiation (power = 0.88), regardless of initial density.
CONCLUSIONS: Human septal chondrocyte monolayers reach confluency from very low initial densities. Growth patterns, cellularity, and differentiation are similar to other starting densities. SIGNIFICANCE: Very low-density monolayers expanded cell number 838-fold in 1 passage and therefore are sufficient for tissue-engineering purposes. This is important because of the requirement of maintaining differentiation and the limitation of small tissue harvest specimens.

Entities:  

Mesh:

Year:  2005        PMID: 16143193     DOI: 10.1016/j.otohns.2005.03.084

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  Insulin-like growth factor-I and growth differentiation factor-5 promote the formation of tissue-engineered human nasal septal cartilage.

Authors:  Thomas H Alexander; August B Sage; Albert C Chen; Barbara L Schumacher; Elliot Shelton; Koichi Masuda; Robert L Sah; Deborah Watson
Journal:  Tissue Eng Part C Methods       Date:  2010-10       Impact factor: 3.056

2.  Differential behavior of auricular and articular chondrocytes in hyaluronic acid hydrogels.

Authors:  Cindy Chung; Isaac E Erickson; Robert L Mauck; Jason A Burdick
Journal:  Tissue Eng Part A       Date:  2008-07       Impact factor: 3.845

3.  Role of Cartilage Forming Cells in Regenerative Medicine for Cartilage Repair.

Authors:  Lin Sun; Michaela R Reagan; David L Kaplan
Journal:  Orthop Res Rev       Date:  2010-09-01

4.  Expansion and redifferentiation of chondrocytes from osteoarthritic cartilage: cells for human cartilage tissue engineering.

Authors:  Nancy D Hsieh-Bonassera; Iwen Wu; Jonathan K Lin; Barbara L Schumacher; Albert C Chen; Koichi Masuda; William D Bugbee; Robert L Sah
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

Review 5.  Engineering cartilage tissue.

Authors:  Cindy Chung; Jason A Burdick
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

6.  Biotechnological Chondroitin a Novel Glycosamminoglycan With Remarkable Biological Function on Human Primary Chondrocytes.

Authors:  Antonietta Stellavato; Virginia Tirino; Francesca de Novellis; Antonella Della Vecchia; Fabio Cinquegrani; Mario De Rosa; Gianpaolo Papaccio; Chiara Schiraldi
Journal:  J Cell Biochem       Date:  2016-05-11       Impact factor: 4.429

7.  Down-Regulation of Transglutaminase 2 Stimulates Redifferentiation of Dedifferentiated Chondrocytes through Enhancing Glucose Metabolism.

Authors:  Kyoung-Won Ko; Bogyu Choi; Sunghyun Park; Yoshie Arai; Won Chul Choi; Joong-Myung Lee; Hojae Bae; In-Bo Han; Soo-Hong Lee
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

Review 8.  Application of Extrusion-Based Hydrogel Bioprinting for Cartilage Tissue Engineering.

Authors:  Fu You; B Frank Eames; Xiongbiao Chen
Journal:  Int J Mol Sci       Date:  2017-07-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.